Therapy News and Research

RSS

Philips' new full face DreamWear mask offers more options for patients with respiratory conditions

Royal Philips, a global leader in health technology, has announced the introduction of the next generation mask in its award-winning DreamWear full face mask system.

From Philips Healthcare 25 Sep 2018

Conquer the Corrugations: Walking together to raise awareness about mental health

Conquer the Corrugations is a Cape York Mental Health Awareness Walk that stretches 42 kilometers from the Coen Information Centre to the Archer River Roadhouse. The goal of the walk is to raise awareness, to support and to remember those affected by mental illness.

25 Sep 2018

Recurrence risk of VTE appears similar for patients with cancer and those with unprovoked VTE

Patients with venous thromboembolism carry a high risk of recurrence. Accordingly, a 16-year Danish prospective cohort study of nearly 74,000 patients with incident VTE concluded that the risk of recurrence is substantial.

25 Sep 2018

Physical activity may have beneficial effects for people with rare Alzheimer's disease

For individuals carrying a genetic mutation that causes Alzheimer's disease, engaging in at least 2.5 hours of physical activity per week may have beneficial effects on markers of Alzheimer's disease brain changes and may delay cognitive decline, according to a new study available online by Alzheimer's & Dementia: The Journal of the Alzheimer's Association as an article in press, corrected proof.

25 Sep 2018

Organs actively fighting back against autoimmune diseases, finds study

Organs affected by autoimmune disease could be fighting back by "exhausting" immune cells that cause damage using methods similar to those used by cancer cells to escape detection, according to a study by researchers at the University of Pittsburgh School of Medicine published today in the Journal of Clinical Investigation.

25 Sep 2018

Hybrid theranostic complex shows high therapeutic efficacy against tumor cells

Emerging cancer nanotechnology enables target-delivery of substantial payloads of drugs to cancer sites with concomitant reduction of side-effects due to the lesser accumulation in the critical organs.

25 Sep 2018

Paralyzed man regains his ability to stand, walk with spinal cord stimulation and physical therapy

Spinal cord stimulation and physical therapy have helped a man paralyzed since 2013 regain his ability to stand and walk with assistance. The results, achieved in a research collaboration between Mayo Clinic and UCLA, are reported in Nature Medicine.

25 Sep 2018

Epidural stimulation and locomotor training helps patients with spinal cord injury to walk

Of four research participants living with traumatic, motor complete spinal cord injury, two are able to walk over ground with epidural stimulation following epidural stimulation paired with daily locomotor training.

25 Sep 2018

Study: Optimizing dopaminergic treatment improves non-motor symptoms and quality of life

Non-motor symptoms are common in late-stage Parkinson's disease as the frequency and severity of most of these symptoms increase with advancing disease. Optimizing dopaminergic treatment in the most severe stages can affect non-motor symptoms and improve quality of life, report scientists in the Journal of Parkinson's Disease.

25 Sep 2018

Researchers reassess negative pressure wound therapy as its benefit and harm remain unclear

About one decade after its first benefit assessment of negative pressure wound therapy, the German Institute for Quality and Efficiency in Health Care is reassessing this treatment method. However, then as now, its benefit and harm are unclear.

25 Sep 2018

Phase 1 and 2 clinical trials of entrectinib drug in ROS1-positive NSCLC show promising results

Results of phase 1 and phase 2 clinical trials of the drug entrectinib in ROS1-positive non-small cell lung cancer presented on the press program of the International Association for the Study of Lung Cancer 19th World Conference on Lung Cancer show a response rate of 77.4 percent for 53 patients evaluable for response, with median duration of response of 24.6 months.

25 Sep 2018

Clinical trial investigators found non-compliant with requirement to report results on EU register

According to EU legislation, clinical trials must be prospectively registered in the European Union Clinical Trials Register and the main results must be reported there one year after completion of the trial. This information is thus publicly available.

25 Sep 2018

Harmful H. pylori may play a role in Parkinson's disease

While human genetic mutations are involved in a small number of Parkinson's disease (PD) cases, the vast majority of cases are of unknown environmental causes, prompting enormous interest in identifying environmental risk factors involved.

25 Sep 2018

Your Vision Matters: How to Protect Your Eyesight

Dr. Neil Ebenezer from the charity Fight for Sight discusses the steps you can take to protect your eyesight into old age, and why research into ophthalmic diseases is desperately needed.

24 Sep 2018

Gene therapy approach could help treat mitochondrial diseases

Researchers have developed a genome-editing tool for the potential treatment of mitochondrial diseases: serious and often fatal conditions which affect 1 in 5,000 people.

24 Sep 2018

New test speeds up diagnosis of multi-resistant pathogens

Researchers at the University of Cologne and the German Center for Infection Research have made an important step towards speeding up the diagnosis of multi-resistant pathogens.

24 Sep 2018

Ancora Heart announces positive data of study evaluating AccuCinch Ventricular Repair System

Ancora Heart, Inc., a company developing a novel therapy to address heart failure, today announced positive clinical data from the company's recently expanded U.S. early feasibility study evaluating the safety of the investigational AccuCinch Ventricular Repair System designed for the treatment of heart failure and functional mitral regurgitation.

24 Sep 2018

Gilead Sciences plans to launch authorized generic versions of Epclusa and Harvoni in the US

Gilead Sciences, Inc. announced today plans to launch authorized generic versions of Epclusa and Harvoni, Gilead's leading treatments for chronic hepatitis C virus, in the United States, through a newly created subsidiary, Asegua Therapeutics LLC.

24 Sep 2018

Alexion announces positive results from Phase 3 PREVENT study of Soliris in patients with NMOSD

Alexion Pharmaceuticals, Inc. today announced positive topline results from the Phase 3 PREVENT study of Soliris in patients with anti-aquaporin-4 auto antibody-positive neuromyelitis optica spectrum disorder.

24 Sep 2018

Genes predicting person's height may provide clues about causes of varicose veins

A person's height and certain genes that predict height are associated with varicose veins and may provide clues about what causes this condition and ways to prevent and treat it, according to new research in the American Heart Association's journal Circulation.

24 Sep 2018

Therapy News and Research

Philips' new full face DreamWear mask offers more options for patients with respiratory conditions

Conquer the Corrugations: Walking together to raise awareness about mental health

Recurrence risk of VTE appears similar for patients with cancer and those with unprovoked VTE

Physical activity may have beneficial effects for people with rare Alzheimer's disease

Organs actively fighting back against autoimmune diseases, finds study

Hybrid theranostic complex shows high therapeutic efficacy against tumor cells

Paralyzed man regains his ability to stand, walk with spinal cord stimulation and physical therapy

Epidural stimulation and locomotor training helps patients with spinal cord injury to walk

Study: Optimizing dopaminergic treatment improves non-motor symptoms and quality of life

Researchers reassess negative pressure wound therapy as its benefit and harm remain unclear

Phase 1 and 2 clinical trials of entrectinib drug in ROS1-positive NSCLC show promising results

Clinical trial investigators found non-compliant with requirement to report results on EU register

Harmful H. pylori may play a role in Parkinson's disease

Your Vision Matters: How to Protect Your Eyesight

Gene therapy approach could help treat mitochondrial diseases

New test speeds up diagnosis of multi-resistant pathogens

Ancora Heart announces positive data of study evaluating AccuCinch Ventricular Repair System

Gilead Sciences plans to launch authorized generic versions of Epclusa and Harvoni in the US

Alexion announces positive results from Phase 3 PREVENT study of Soliris in patients with NMOSD

Genes predicting person's height may provide clues about causes of varicose veins

Industry Focus eBook - Cell biology (5th edition) eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News